Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK
出版年份 2013 全文链接
标题
Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK
作者
关键词
-
出版物
EMBO Molecular Medicine
Volume 5, Issue 11, Pages 1759-1774
出版商
EMBO
发表日期
2013-10-12
DOI
10.1002/emmm.201302732
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Impact of Intertumoral Heterogeneity on Predicting Chemotherapy Response of BRCA1-Deficient Mammary Tumors
- (2012) S. Rottenberg et al. CANCER RESEARCH
- The p57 CDKi integrates stress signals into cell-cycle progression to promote cell survival upon stress
- (2012) Manel Joaquin et al. EMBO JOURNAL
- Phosphorylated p38 and JNK MAPK proteins in hepatocellular carcinoma
- (2012) Shen-Nien Wang et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Non-Classical P38 Map Kinase Functions: Cell Cycle Checkpoints and Survival
- (2012) Tina M. Thornton et al. International Journal of Biological Sciences
- Cryptotanshinone induces ER stress-mediated apoptosis in HepG2 and MCF7 cells
- (2011) In-Ja Park et al. APOPTOSIS
- Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy
- (2011) Christophe Glorieux et al. BIOCHEMICAL PHARMACOLOGY
- Global Proteomic Assessment of the Classical Protein-Tyrosine Phosphatome and “Redoxome”
- (2011) Robert Karisch et al. CELL
- Regulation of protein tyrosine phosphatases by reversible oxidation
- (2011) Arne Östman et al. JOURNAL OF BIOCHEMISTRY
- p38α Mediates Cell Survival in Response to Oxidative Stress via Induction of Antioxidant Genes
- (2011) Álvaro Gutiérrez-Uzquiza et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selective killing of cancer cells by a small molecule targeting the stress response to ROS
- (2011) Lakshmi Raj et al. NATURE
- miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
- (2011) Bogdan Mateescu et al. NATURE MEDICINE
- Balance between MKK6 and MKK3 Mediates p38 MAPK Associated Resistance to Cisplatin in NSCLC
- (2011) Eva M. Galan-Moya et al. PLoS One
- Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress
- (2011) A. T. Shaw et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic analysis of specific and redundant roles for p38 and p38 MAPKs during mouse development
- (2011) I. del Barco Barrantes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms and functions of p38 MAPK signalling
- (2010) Ana Cuadrado et al. BIOCHEMICAL JOURNAL
- Cancer cell killing via ROS: To increase or decrease, that is the question
- (2010) Jie Wang et al. CANCER BIOLOGY & THERAPY
- Mitochondrial ROS and radiation induced transformation in mouse embryonic fibroblasts
- (2010) Changbin Du et al. CANCER BIOLOGY & THERAPY
- p38 Mitogen-Activated Protein Kinase Promotes Cell Survival in Response to DNA Damage but Is Not Required for the G2 DNA Damage Checkpoint in Human Cancer Cells
- (2010) M. S. Phong et al. MOLECULAR AND CELLULAR BIOLOGY
- Inhibition of p38α unveils an AMPK-FoxO3A axis linking autophagy to cancer-specific metabolism
- (2009) Fulvio Chiacchiera et al. Autophagy
- Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation
- (2009) Wei Wang et al. BIOCHEMICAL PHARMACOLOGY
- Structural Bioinformatics-Based Prediction of Exceptional Selectivity of p38 MAP Kinase Inhibitor PH-797804
- (2009) Li Xing et al. BIOCHEMISTRY
- Inhibition of the p38 Kinase Suppresses the Proliferation of Human ER-Negative Breast Cancer Cells
- (2009) L. Chen et al. CANCER RESEARCH
- p38 Mitogen-Activated Protein Kinase Is Essential for Skin Tumor Development in Mice
- (2009) E. M. Schindler et al. CANCER RESEARCH
- A High-Throughput Pharmaceutical Screen Identifies Compounds with Specific Toxicity against BRCA2-Deficient Tumors
- (2009) B. Evers et al. CLINICAL CANCER RESEARCH
- Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders
- (2009) David M. Goldstein et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anti-Inflammatory Properties of a Novel N-Phenyl Pyridinone Inhibitor of p38 Mitogen-Activated Protein Kinase: Preclinical-to-Clinical Translation
- (2009) H. R. Hope et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Signal cross talks for sustained MAPK activation and cell migration: the potential role of reactive oxygen species
- (2008) Wen-Sheng Wu et al. CANCER AND METASTASIS REVIEWS
- Dual-specificity MAP kinase phosphatases (MKPs) and cancer
- (2008) Stephen M. Keyse CANCER AND METASTASIS REVIEWS
- Reactive Oxygen Species-Mediated Pancreatic β-Cell Death Is Regulated by Interactions between Stress-Activated Protein Kinases, p38 and c-Jun N-Terminal Kinase, and Mitogen-Activated Protein Kinase Phosphatases
- (2008) Ni Hou et al. ENDOCRINOLOGY
- Apoptosis Signal-Regulating Kinase 1 in Stress and Immune Response
- (2007) Kohsuke Takeda et al. Annual Review of Pharmacology and Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More